Generation Bio

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Generation Bio and other ETFs, options, and stocks.

About GBIO

Generation Bio Co. is a genetic medicine company, which focuses on creating a new class of gene therapy to provide durable and redosable treatment for patients suffering from both rare and prevalent diseases. Its non-viral platform incorporates a proprietary high-capacity DNA construct called closed-ended DNA, or ceDNA, a novel cell-targeted lipid nanoparticle delivery system, or ctLNP, and an established, scalable capsid-free manufacturing process.

CEO

Cameron Geoffrey McDonough

CEOCameron Geoffrey McDonough

Employees

115

Employees115

Headquarters

Cambridge, Massachusetts

HeadquartersCambridge, Massachusetts

Founded

2016

Founded2016

Employees

115

Employees115

GBIO Key Statistics

Market cap

27.24M

Market cap27.24M

Price-Earnings ratio

-0.37

Price-Earnings ratio-0.37

Dividend yield

—

Dividend yield—

Average volume

621.20K

Average volume621.20K

High today

$0.407

High today$0.407

Low today

$0.4019

Low today$0.4019

Open price

$0.4019

Open price$0.4019

Volume

14.43K

Volume14.43K

52 Week high

$3.65

52 Week high$3.65

52 Week low

$0.316

52 Week low$0.316

Analyst ratings

67%

of 6 ratings

Buy

66.7%

Hold

33.3%

Sell

People also own

Based on the portfolios of people who own GBIO. This list is generated using Robinhood data, and it’s not a recommendation.